Novartis New Organizational Model

Top 2022 priorities for Novartis 1 Successful launches: LeqvioⓇ, KesimptaⓇ, 177 Lu-PSMA-617, ScemblixⓇ 2 Maintain growth momentum: YC E ►Z KKL 3 Progress pipeline: 20+ assets with significant sales potential, approval by 2026, on track 4 Optimize portfolio: Sandoz review, update end 2022; disciplined BD 5 Deliver returns: Continue productivity initiatives, especially manufacturing, business services 6 Reinforce foundations: Culture to drive performance, data science to drive value, ESG leadership 6 NOVARTIS NEW ORGANIZATIONAL MODEL | APRIL 04, 2022 | NOVARTIS INVESTOR PRESENTATION NOVARTIS | Reimagining Medicine

View entire presentation